Sherif Heiba, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- PET-CT scan
- Nuclear medicine
Get to Know Me
I am a board-certified, fellowship-trained doctor trained in nuclear medicine, a specialty within radiology that uses radioactive substances to diagnose and treat cancer and other diseases. I have extensive experience in all fields of nuclear medicine and molecular imaging, a type of medical imaging that focuses on imaging at the molecular and cellular level which can help better diagnose and treat some types of cancer
I am experienced in interpreting all types of positron emission tomography–computed tomography (PET-CT) scans using the latest technology. This includes:
- PET-CT scans that use different radioactive tracers that help detect cancer.
- Prostate-specific membrane antigen (PSMA) PET scan, a type of scan that can help diagnose metastatic or advanced prostate cancer.
- Beta Amyloid PET-CT scan, a type of imaging that can detect high levels of the beta amyloid protein, or plaque, in the brain.
Throughout my career, I have gained the trust of doctors in various specialties by providing timely and accurate information on patients’ screening, diagnosis, and follow-up. I also provide guidance and support through direct communication and participate in tumor boards where a group of cancer specialists come together to discuss diagnosis and treatment options for individual patients or to share knowledge.
I’m a nuclear medicine physician, a doctor with special training in using radioactive drugs to diagnose and treat disease.
- Associate Attending Physician
My Specialties
- PET-CT scan
- Nuclear medicine
Education
- MD, Alexandria University School of Medicine
Residencies
- University of Miami/Jackson Memorial Hospital
- University of Arizona Health Sciences
Fellowships
- Nuclear Medicine, University of Washington Medical Center
Board Certifications
- American Board of Nuclear Medicine
Awards and Honors
- Residency Program Director Performance Award, Icahn School of Medicine at Mount Sinai (2019)
- Asa E. Seeds Memorial Award in Nuclear Medicine, University of Washington (1993)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Palestro C, Clark A, Grady E, Heiba S, Israel O, Klitzke A, Love C, Sathekge M, Treves T, Yarbrough T. Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging. J Nucl Med 2021;62:1815-1831.
Heiba S, Jiang M, Rivera J, Genden E, Inabnet III W, Machac J, Kostakoglu L. Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clin Nucl Med 2015;40:476-482.
Heiba S, Kolker D, Ong L, Sharma S, Travis A, Teodorescu V, Ellozy S, Kostakoglu L, Savitch I, Machac, J. Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources. Nucl Med Commun 2013;34:877-884.
Son H, Kositwattanarerk A, Hayes MP, Chuang L, Rahaman J, Heiba S, Machac J, Zakashansky K, Kostakoglu L. PET/CT evaluation of cervical cancer: spectrum of disease. Radiographics 2010;30:1251-68.
Visit PubMed for a full listing of Dr. Heiba’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Sherif Heiba discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.